{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:52:18Z","timestamp":1785865938820,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1038\/s41417-021-00377-7","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T08:03:12Z","timestamp":1631606592000},"page":"930-939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Overexpression of microRNA-130a represses uveal melanoma cell migration and invasion through inactivation of the Wnt\/\u03b2-catenin signaling pathway by downregulating USP6"],"prefix":"10.1038","volume":"29","author":[{"given":"Shuai","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1822-8380","authenticated-orcid":false,"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"377_CR1","first-page":"573974","volume":"2011","author":"VP Papastefanou","year":"2011","unstructured":"Papastefanou VP, Cohen VM. Uveal melanoma. J Ski Cancer. 2011;2011:573974.","journal-title":"J Ski Cancer"},{"key":"377_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","volume":"3","author":"SJ Furney","year":"2013","unstructured":"Furney SJ, Pedersen M, Gentien D, Dumont AG, Rapinat A, Desjardins L, et al. SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov. 2013;3:1122\u20139.","journal-title":"Cancer Discov"},{"key":"377_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1070-7","volume":"18","author":"J Zhang","year":"2019","unstructured":"Zhang J, Liu S, Ye Q, Pan J. Transcriptional inhibition by CDK7\/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma. Mol Cancer. 2019;18:140.","journal-title":"Mol Cancer"},{"key":"377_CR4","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1080\/02713683.2017.1297997","volume":"42","author":"T Nayman","year":"2017","unstructured":"Nayman T, Bostan C, Logan P, Burnier MN Jr. Uveal melanoma risk factors: a systematic review of meta-analyses. Curr Eye Res. 2017;42:1085\u201393.","journal-title":"Curr Eye Res"},{"key":"377_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2014.04.017","volume":"25","author":"FX Yu","year":"2014","unstructured":"Yu FX, Luo J, Mo JS, Liu G, Kim YC, Meng Z, et al. Mutant Gq\/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell. 2014;25:822\u201330.","journal-title":"Cancer Cell"},{"key":"377_CR6","first-page":"1353","volume":"26","author":"J Tie","year":"2011","unstructured":"Tie J, Fan D. Big roles of microRNAs in tumorigenesis and tumor development. Histol Histopathol. 2011;26:1353\u201361.","journal-title":"Histol Histopathol"},{"key":"377_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-015-0185-1","volume":"15","author":"KB Reddy","year":"2015","unstructured":"Reddy KB. MicroRNA (miRNA) in cancer. Cancer Cell Int. 2015;15:38.","journal-title":"Cancer Cell Int"},{"key":"377_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s12282-017-0776-x","volume":"24","author":"HD Zhang","year":"2017","unstructured":"Zhang HD, Jiang LH, Sun DW, Li J, Ji ZL. The role of miR-130a in cancer. Breast Cancer. 2017;24:521\u20137.","journal-title":"Breast Cancer"},{"key":"377_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05023-9","volume":"9","author":"H Ishii","year":"2018","unstructured":"Ishii H, Vodnala SK, Achyut BR, So JY, Hollander MC, Greten TF, et al. miR-130a and miR-145 reprogram Gr-1(+)CD11b(+) myeloid cells and inhibit tumor metastasis through improved host immunity. Nat Commun. 2018;9:2611.","journal-title":"Nat Commun"},{"key":"377_CR10","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.1158\/0008-5472.CAN-17-0530","volume":"77","author":"H Wei","year":"2017","unstructured":"Wei H, Cui R, Bahr J, Zanesi N, Luo Z, Meng W, et al. miR-130a deregulates PTEN and stimulates tumor growth. Cancer Res. 2017;77:6168\u201378.","journal-title":"Cancer Res"},{"key":"377_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000452540","volume":"40","author":"L Cui","year":"2016","unstructured":"Cui L, Li Y, Lv X, Li J, Wang X, Lei Z, et al. Expression of microRNA-301a and its functional roles in malignant melanoma. Cell Physiol Biochem. 2016;40:230\u201344.","journal-title":"Cell Physiol Biochem"},{"key":"377_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2013.03.005","volume":"45","author":"AM Oliveira","year":"2014","unstructured":"Oliveira AM, Chou MM. USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. Hum Pathol. 2014;45:1\u201311.","journal-title":"Hum Pathol"},{"key":"377_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1172\/JCI71602","volume":"124","author":"NM Weathington","year":"2014","unstructured":"Weathington NM, Mallampalli RK. Emerging therapies targeting the ubiquitin proteasome system in cancer. J Clin Invest. 2014;124:6\u201312.","journal-title":"J Clin Invest"},{"key":"377_CR14","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1128\/MCB.01094-10","volume":"31","author":"TT Lui","year":"2011","unstructured":"Lui TT, Lacroix C, Ahmed SM, Goldenberg SJ, Leach CA, Daulat AM, et al. The ubiquitin-specific protease USP34 regulates axin stability and Wnt\/beta-catenin signaling. Mol Cell Biol. 2011;31:2053\u201365.","journal-title":"Mol Cell Biol"},{"key":"377_CR15","doi-asserted-by":"publisher","first-page":"E2945","DOI":"10.1073\/pnas.1605691113","volume":"113","author":"B Madan","year":"2016","unstructured":"Madan B, Walker MP, Young R, Quick L, Orgel KA, Ryan M, et al. USP6 oncogene promotes Wnt signaling by deubiquitylating Frizzleds. Proc Natl Acad Sci USA. 2016;113:E2945\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"377_CR16","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1074\/jbc.M117.819300","volume":"293","author":"X Zhu","year":"2018","unstructured":"Zhu X, Yuan C, Tian C, Li C, Nie F, Song X, et al. The plant sesquiterpene lactone parthenolide inhibits Wnt\/beta-catenin signaling by blocking synthesis of the transcriptional regulators TCF4\/LEF1. J Biol Chem. 2018;293:5335\u201344.","journal-title":"J Biol Chem"},{"key":"377_CR17","doi-asserted-by":"publisher","first-page":"115102","DOI":"10.1088\/1361-6528\/ab5a03","volume":"31","author":"G Yang","year":"2020","unstructured":"Yang G, Zhang J, You W, Zhao X, Hou P, He W, et al. Targeted disruption of the BCL9\/beta-catenin interaction by endosomal-escapable nanoparticles functionalized with an E-cadherin-derived peptide. Nanotechnology. 2020;31:115102.","journal-title":"Nanotechnology."},{"key":"377_CR18","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.7150\/thno.17451","volume":"7","author":"J Zhou","year":"2017","unstructured":"Zhou J, Jin B, Jin Y, Liu Y, Pan J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo. Theranostics. 2017;7:1447\u201362.","journal-title":"Theranostics."},{"key":"377_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649\u201358.","journal-title":"Neoplasia."},{"key":"377_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ng.2523","volume":"45","author":"JW Harbour","year":"2013","unstructured":"Harbour JW, Roberson ED, Anbunathan H, Onken MD, Worley LA, Bowcock AM. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet. 2013;45:133\u20135.","journal-title":"Nat Genet"},{"key":"377_CR21","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","volume":"22","author":"MG Field","year":"2016","unstructured":"Field MG, Decatur CL, Kurtenbach S, Gezgin G, van der Velden PA, Jager MJ, et al. PRAME as an independent biomarker for metastasis in uveal melanoma. Clin Cancer Res. 2016;22:1234\u201342.","journal-title":"Clin Cancer Res"},{"key":"377_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/CMR.0b013e3282feeac6","volume":"18","author":"LA Worley","year":"2008","unstructured":"Worley LA, Long MD, Onken MD, Harbour JW. Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res. 2008;18:184\u201390.","journal-title":"Melanoma Res"},{"key":"377_CR23","first-page":"673","volume":"37","author":"D Wang","year":"2015","unstructured":"Wang D, Li YJ, Ding N, Wang JY, Yang Q, Yang YR, et al. [Molecular networks and mechanisms of epithelial-mesenchymal transition regulated by miRNAs in the malignant melanoma cell line]. Yi Chuan. 2015;37:673\u201382.","journal-title":"Yi Chuan"},{"key":"377_CR24","doi-asserted-by":"publisher","first-page":"e0154915","DOI":"10.1371\/journal.pone.0154915","volume":"11","author":"J Sha","year":"2016","unstructured":"Sha J, Gastman BR, Morris N, Mesinkovska NA, Baron ED, Cooper KD, et al. The response of microRNAs to solar UVR in skin-resident melanocytes differs between melanoma patients and healthy persons. PLoS ONE. 2016;11:e0154915.","journal-title":"PLoS ONE"},{"key":"377_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0230-2","volume":"31","author":"B Li","year":"2014","unstructured":"Li B, Huang P, Qiu J, Liao Y, Hong J, Yuan Y. MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis. Med Oncol. 2014;31:230.","journal-title":"Med Oncol"},{"key":"377_CR26","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1002\/cam4.1618","volume":"7","author":"W Peng","year":"2018","unstructured":"Peng W, Liu YN, Zhu SQ, Li WQ, Guo FC. The correlation of circulating pro-angiogenic miRNAs\u2019 expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer. Cancer Med. 2018;7:3773\u201391.","journal-title":"Cancer Med"},{"key":"377_CR27","doi-asserted-by":"crossref","unstructured":"Campos-Iglesias D, L\u00f3pez-Ot\u00edn C, Freije JJC-LP. Ubiquitin-specific proteases as targets for anticancer drug therapies. Cancer Lead Protease. 2020;73\u2013120.","DOI":"10.1016\/B978-0-12-818168-3.00004-8"},{"key":"377_CR28","doi-asserted-by":"crossref","unstructured":"Zhao Y, Xue C, Xie Z, Ouyang X, Li LJCP. Comprehensive analysis of ubiquitin-specific protease 1 reveals its importance in hepatocellular carcinoma. Cell Prolif. 2020;53:e12908.","DOI":"10.1111\/cpr.12908"},{"key":"377_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.33594\/000000127","volume":"53","author":"HH Nguyen","year":"2019","unstructured":"Nguyen HH, Kim T, Nguyen T, Hahn MJ, Yun SI, Kim KK. A selective inhibitor of ubiquitin-specific protease 4 suppresses colorectal cancer progression by regulating beta-catenin signaling. Cell Physiol Biochem. 2019;53:157\u201371.","journal-title":"Cell Physiol Biochem"},{"key":"377_CR30","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2147\/OTT.S176582","volume":"12","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Liang P, Ji W, Yu Z, Chen H, Jiang L. Ubiquitin-specific protease 4 promotes glioblastoma multiforme via activating ERK pathway. Onco Targets Ther. 2019;12:1825\u201339.","journal-title":"Onco Targets Ther"},{"key":"377_CR31","first-page":"955","volume":"8","author":"Q Li","year":"2016","unstructured":"Li Q, Wu Y, Zhang J, Yi T, Li W. MicroRNA-130a regulates cell malignancy by targeting RECK in chronic myeloid leukemia. Am J Transl Res. 2016;8:955\u201367.","journal-title":"Am J Transl Res"},{"key":"377_CR32","doi-asserted-by":"crossref","unstructured":"Chen X, Yue B, Zhang C, Qi M, Qiu J, Wang Y, et al. MiR-130a-3p inhibits the viability, proliferation, invasion, and cell cycle, and promotes apoptosis of nasopharyngeal carcinoma cells by suppressing BACH2 expression. Biosci Rep. 2017;37:BSR20160576.","DOI":"10.1042\/BSR20160576"},{"key":"377_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-016-0296-0","volume":"35","author":"Y Liu","year":"2016","unstructured":"Liu Y, Li Y, Wang R, Qin S, Liu J, Su F, et al. MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells. J Exp Clin Cancer Res. 2016;35:19.","journal-title":"J Exp Clin Cancer Res"},{"key":"377_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/boc.201100108","volume":"104","author":"C Rueckert","year":"2012","unstructured":"Rueckert C, Haucke V. The oncogenic TBC domain protein USP6\/TRE17 regulates cell migration and cytokinesis. Biol Cell. 2012;104:22\u201333.","journal-title":"Biol Cell"},{"key":"377_CR35","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.bbrc.2018.08.168","volume":"505","author":"H Zeng","year":"2018","unstructured":"Zeng H, Yuan F, Mi Y, Xian G, Qin C, Zhang D. As an independent prognostic factor, USP6 promotes the invasion and metastasis of colon cancer. Biochem Biophys Res Commun. 2018;505:816\u201322.","journal-title":"Biochem Biophys Res Commun"},{"key":"377_CR36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/abbs\/gmx089","volume":"49","author":"L Zheng","year":"2017","unstructured":"Zheng L, Liu Y, Pan J. Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt\/beta-catenin pathway. Acta Biochim Biophys Sin (Shanghai). 2017;49:890\u20138.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"377_CR37","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.4049\/jimmunol.1102282","volume":"189","author":"T Yaguchi","year":"2012","unstructured":"Yaguchi T, Goto Y, Kido K, Mochimaru H, Sakurai T, Tsukamoto N, et al. Immune suppression and resistance mediated by constitutive activation of Wnt\/beta-catenin signaling in human melanoma cells. J Immunol. 2012;189:2110\u20137.","journal-title":"J Immunol"},{"key":"377_CR38","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/CMR.0b013e3282f1d302","volume":"17","author":"W Zuidervaart","year":"2007","unstructured":"Zuidervaart W, Pavey S, van Nieuwpoort FA, Packer L, Out C, Maat W, et al. Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma. Melanoma Res. 2007;17:380\u20136.","journal-title":"Melanoma Res"},{"key":"377_CR39","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fphar.2017.00877","volume":"8","author":"H Dou","year":"2017","unstructured":"Dou H, Shen R, Tao J, Huang L, Shi H, Chen H, et al. Curcumin suppresses the colon cancer proliferation by inhibiting Wnt\/beta-catenin pathways via miR-130a. Front Pharmacol. 2017;8:877.","journal-title":"Front Pharmacol"},{"key":"377_CR40","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bbrc.2012.07.127","volume":"425","author":"N Xu","year":"2012","unstructured":"Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q, et al. Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun. 2012;425:468\u201372.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00377-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00377-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00377-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T23:03:27Z","timestamp":1658185407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00377-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["377"],"URL":"https:\/\/doi.org\/10.1038\/s41417-021-00377-7","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}